Related Experiment Video

Updated: Aug 10, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Future directions in thrombolysis

J T Willerson1, P Zoldhelyi

  • 1Department of Medicine, University of Texas Medical School at Houston 77225, USA.

Clinical Cardiology
|September 24, 1999
PubMed

Insights

Research over 25 years clarifies acute coronary syndromes and thrombosis. New antithrombotic therapies and drug targets are emerging for managing coronary artery disease.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Pharmacology

Background:

  • Extensive research over 25 years has elucidated the mechanisms and pathogenesis of acute coronary syndromes and occlusive vascular disease.
  • Thrombosis is understood to result from vascular injury, making thrombus lysis and prevention of reocclusion critical for treatment.
  • Advances in understanding vascular-wall-platelet and platelet-platelet interactions, along with coagulation, have identified numerous drug targets and antithrombotic agents.

Purpose of the Study:

  • To review emerging antithrombotic therapies.
  • To introduce potential future molecular targets for drug discovery.
  • To discuss novel strategies for managing patients with coronary artery disease.

Main Methods:

  • Literature review of research on acute coronary syndromes, thrombosis, and antithrombotic therapies.
  • Analysis of biological and molecular mechanisms in vascular-wall-platelet and platelet-platelet interactions, and coagulation.
  • Synthesis of information on current and future drug discovery targets and patient management strategies.

Main Results:

  • Established understanding of thrombosis mechanisms and pathogenesis in coronary artery disease.
  • Identification of multiple drug targets and development of numerous antithrombotic drugs.
  • Emerging antithrombotic therapies and novel management strategies are under investigation.

Conclusions:

  • Continued research has significantly advanced the understanding of coronary artery disease and thrombosis.
  • Multiple therapeutic targets and antithrombotic drugs have been developed.
  • Future research will focus on novel therapies and management strategies for coronary artery disease.

More Related Videos

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model06:16

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model

Published on: April 19, 2024

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...